Lelias S - EpiVax, Inc. - Informatics and Immunology

A SARS-CoV-2 T cell epitope homologous to a validated human Treg epitope (Tregitope) suppresses CD4 and CD8 T cell memory responses

by Corey Iacono | Aug 29, 2022

A SARS-CoV-2 T cell epitope homologous to a validated human Treg epitope (Tregitope) suppresses CD4 and CD8 T cell memory responses Shah Md. Shahjahan Miah, Andres Gutierrez, Sandra Lelias, Christine M. Boyle, Lenny Moise, Anne S. De Groot EpiVax Inc, Providence, RI...

Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Rare Diseases

by Riley Nolan | Mar 21, 2022

Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Rare Diseases

Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease

by Riley Nolan | Jun 22, 2021

Tregitopes Improve Asthma by Promoting Highly Suppressive and Antigen-Specific Tregs

by Riley Nolan | Apr 20, 2021

Identification of a potent regulatory T cell epitope infactor V that modulates CD4+ and CD8+ memory T cell responses

by Annie De Groot | Jan 13, 2021

FV621 De Groot et al 2021

A SARS-CoV-2 T cell epitope homologous to a validated human Treg epitope (Tregitope) suppresses CD4 and CD8 T cell memory responses

Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Rare Diseases

Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease

Tregitopes Improve Asthma by Promoting Highly Suppressive and Antigen-Specific Tregs

Identification of a potent regulatory T cell epitope infactor V that modulates CD4+ and CD8+ memory T cell responses

Recent Posts

Categories